WASHINGTON, July 27, 2016 /PRNewswire-USNewswire/ — The Bio-Process Systems Alliance (BPSA) is pleased to announce the 1st International Single-Use Summit Europe (BPSA EUS) will be held September 26-28, 2016, in Barcelona, Spain, with a primary focus on the global promise and expanded deployment prospects for single-use technologies (SUTs).
Technical topics will be blended with business and regulatory presentations to provide a mix of issues that surround the rapid global emergence of single-use as the “go-to” platform in bioprocessing.
“This unique coupling of technical and business topics is the key to the value of our program in Europe,” said John Boehm of CPC and Chairman of BPSA’s Board of Directors. “For component manufacturers, system integrators and especially users, risk-mitigation is the key to accelerated adoption of single-use in biopharmaceutical manufacturing. We will address key technical topics in-depth, as well as provide context to the current business climate, inclusive of EU government initiatives and overall projected market growth. It’s going to be interesting and informative for all, and we believe our choice of venue, Barcelona, will prove to be a convenient gathering point for the industry.”
Speakers and panelists for the EUS 2016:
“With our inaugural event in Europe, we have put together a program that will appeal to CEOs, manufacturing VPs, quality-assurance experts, single-use systems integrators, educators and vaccine and biopharma providers,” said Kevin Ott, Executive Director of BPSA. “This meeting is dedicated to addressing everything you need to know about single-use…right now…for users and suppliers that are focused not just in North America, but also in Europe, Asia and Latin America. We hope this event will allow BPSA to expand its educational reach globally, as single-use quickly migrates more and more toward global commercial production use for biologic drugs and vaccines.”
The summit will be held at the Crowne Plaza Hotel, Barcelona. The full agenda, registration and hotel information can be viewed on the European Summit page. “We look forward to seeing everyone at this can’t miss industry focused event,” Ott said.
The Bio-Process Systems Alliance (BPSA) was formed in 2005 as an industry-led corporate member trade association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. For more information, please visit www.bpsalliance.org, or contact Kevin Ott, Executive Director, at firstname.lastname@example.org.
SOURCE Bio-Process Systems Alliance (BPSA)